Completion of Genetic Testing and Incidence of Pathogenic Germline Mutation among Patients with Early-Onset Colorectal Cancer: A Single Institution Analysis.

colorectal cancer early-onset germline testing pathogenic variant

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
11 Jul 2023
Historique:
received: 12 06 2023
revised: 30 06 2023
accepted: 07 07 2023
medline: 29 7 2023
pubmed: 29 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Over the past 20 years, rates of early-onset colorectal cancer (eoCRC), defined as <50 years of age at diagnosis, have increased, with 16-25% associated with a pathogenic germline variant (PGV) resulting in a hereditary cancer syndrome. In the present study, we sought to further characterize PGVs observed in patients with eoCRC. We conducted a retrospective analysis of patients with a history of CRC referred for genetic counseling at Mayo Clinic Rochester between April 2019 and April 2022. Three hundred and three CRC patients were referred to medical genetics, including 124 with a history of eoCRC. Only 84 patients (68%) with eoCRC referred for genetic counseling completed genetic testing, with an average of 48 genes evaluated. PGVs were identified in 27.4% with eoCRC, including 8.3% with Lynch syndrome (LS). Other detected PGVs known to increase the risk of CRC included

Identifiants

pubmed: 37509234
pii: cancers15143570
doi: 10.3390/cancers15143570
pmc: PMC10377669
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : NCI NIH HHS
ID : P30 CA015083
Pays : United States

Références

Gut. 2019 Dec;68(12):2179-2185
pubmed: 31488504
Lancet Gastroenterol Hepatol. 2022 Mar;7(3):262-274
pubmed: 35090605
JCO Precis Oncol. 2021 May 05;5:
pubmed: 34250417
Lancet Gastroenterol Hepatol. 2019 Jul;4(7):511-518
pubmed: 31105047
Gastroenterology. 2018 Mar;154(4):897-905.e1
pubmed: 29146522
Mod Pathol. 2012 Aug;25(8):1128-39
pubmed: 22481281
Gastroenterology. 2010 Jun;138(6):2044-58
pubmed: 20420945
Clin Gastroenterol Hepatol. 2022 Mar;20(3):e508-e528
pubmed: 33857637
JAMA Oncol. 2017 Apr 01;3(4):464-471
pubmed: 27978560
Pathology. 2018 Jan;50(1):49-59
pubmed: 29169633
J Clin Oncol. 2017 Apr 1;35(10):1086-1095
pubmed: 28135145
JAMA Surg. 2021 Sep 1;156(9):865-874
pubmed: 34190968
Nat Rev Clin Oncol. 2021 Apr;18(4):230-243
pubmed: 33219329
J Natl Compr Canc Netw. 2021 Jan 06;19(1):77-102
pubmed: 33406487
Dis Colon Rectum. 2023 Apr 1;66(4):531-542
pubmed: 35195555
JAMA Oncol. 2019 Jan 1;5(1):37-44
pubmed: 30326010
N Engl J Med. 2022 Apr 21;386(16):1547-1558
pubmed: 35443109
J Natl Cancer Inst. 2021 Nov 29;113(12):1683-1692
pubmed: 34405229
J Clin Oncol. 2009 Aug 20;27(24):3975-80
pubmed: 19620482
Genes Chromosomes Cancer. 2022 Feb;61(2):105-113
pubmed: 34761457
JAMA. 2021 May 18;325(19):1965-1977
pubmed: 34003218
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593

Auteurs

Michael H Storandt (MH)

Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.

Kara R Rogen (KR)

Department of Clinical Genomics, Mayo Clinic, Rochester, MN 55905, USA.

Anushka Iyyangar (A)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Rylie R Schnell (RR)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Jessica L Mitchell (JL)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Joleen M Hubbard (JM)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Frank A Sinicrope (FA)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Aminah Jatoi (A)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Amit Mahipal (A)

Department of Oncology, University Hospitals Seidman Cancer Center and Case Western Reserve University, Cleveland, OH 44106, USA.

Qian Shi (Q)

Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN 55905, USA.

Zhaohui Jin (Z)

Department of Oncology, Mayo Clinic, Rochester, MN 55905, USA.

Classifications MeSH